Economic consequences incurred by living kidney donors: A canadian multi-center prospective study

American Journal of Transplantation

Volumn 14, Issue 4, 2014, Pages 916-922

  Klarenbach, S ^a   Gill, J S ^b   Knoll, G ^c   Caulfield, T ^d   Boudville, N ^e   Prasad, G V R ^f   Karpinski, M ^g   Storsley, L ^g   Treleaven, D ^h   Arnold, J ⁱ   Cuerden, M ⁱ   Jacobs, P ^a   Garg, A X ^h,i  

^a INSTITUTE OF HEALTH ECONOMICS   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF MANITOBA   (Canada)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Cost of illness; costs and cost analysis; kidney transplantation; living donors

Indexed keywords

ADULT; AVIATION; CANADA; CAUCASIAN; ECONOMIC ASPECT; FEMALE; FOLLOW UP; HEALTH CARE COST; HOUSEHOLD; HUMAN; INCOME; KIDNEY DONOR; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REIMBURSEMENT; REVIEW; CLINICAL TRIAL; COST; DONOR; ECONOMICS; HOSPITALIZATION; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; NEPHRECTOMY; POSTOPERATIVE PERIOD; PROGNOSIS; SELF CARE; TRANSPLANTATION; TRAVEL; TRENDS;

COSTS AND COST ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HEALTH EXPENDITURES; HOSPITALIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEPHRECTOMY; POSTOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; SELF CARE; TISSUE AND ORGAN HARVESTING; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TRAVEL;

EID: 84897115166     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12662     Document Type: Review

References (20)

1. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730.
2. Laupacis A, Keown P, Pus N, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996; 50: 235-242.
3. Whiting JF, Kiberd B, Kalo Z, Keown P, Roels L, Kjerulf M., Cost-effectiveness of organ donation: Evaluating investment into donor action and other donor initiatives. Am J Transplant 2004; 4: 569-573.
4. Klarenbach S, Barnieh L, Gill J., Is living kidney donation the answer to the economic problem of end-stage renal disease ? Semin Nephrol 2009; 29: 533-538.
5. Metzger RA, Delmonico FL, Feng S, Port FK, Wynn JJ, Merion RM., Expanded criteria donors for kidney transplantation. Am J Transplant 2003; 3: 114-125.
6. Bingaman AW, Wright FH, Murphey CL., Kidney paired donation in live-donor kidney transplantation [letter]. N Engl J Med 2010; 363: 1091-1092.
7. Park WD, Grande JP, Ninova D, et al. Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant 2003; 3: 952-960.
8. Canadian Institute for Health Information. Canadian Organ Replacement Register annual report: Treatment of end-stage organ failure in Canada. Ottawa, Ontario, Canada: CIHI, 2011.
9. Boulware LE, Ratner LE, Sosa JA, et al. The general public's concerns about clinical risk in live kidney donation. Am J Transplant 2002; 2: 186-193.
10. Klarenbach S, Garg AX, Vlaicu S., Living organ donors face financial barriers: A national reimbursement policy is needed. CMAJ 2006; 174: 797-798.
11. Wiseman AC., Removing financial disincentives to organ donation: An acceptable next step ? Clin J Am Soc Nephrol 2012; 7: 1917-1919.
12. Clarke KS, Klarenbach S, Vlaicu S, Yang RC, Garg AX., The direct and indirect economic costs incurred by living kidney donors-A systematic review. Nephrol Dial Transplant 2006; 21: 1952-1960.
13. Jacobs C., The case for a fair compensation policy of economic consequences incurred by living kidney donors. Nephrol Dial Transplant 2006; 21: 1764-1765.
14. Gold MR, Siegel J, Russell LB, Weinstein MC., Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996.
15. Revicki DA, Irwin D, Reblando J, Simon GE., The accuracy of self-reported disability days. Med Care 1994; 32: 401-404.
16. Jacobs P, Fassbender K., The measurement of indirect costs in the health economics evaluation literature. A review. Int J Technol Assess Health Care 1998; 14: 799-808.
17. Statistics Canada. Average income after tax by economic family types (2007 to 2011). Ottawa, Ontario, Canada: Statistics Canada, 2013.
18. Jacobs C, Thomas C., Financial considerations in living organ donation. Prog Transplant 2003; 13: 130-136.
19. Gaston RS, Danovitch GM, Epstein RA, Kahn JP, Matas AJ, Schnitzler MA., Limiting financial disincentives in live organ donation: A rational solution to the kidney shortage. Am J Transplant 2006; 6: 2548-2555.
20. Canadian Council for Donation and Transplantation. Enhancing living donation: A Canadian forum. Edmonton, Alberta, Canada, 2006. Available at: http://publications.gc.ca/collections/collection-2007/hc-sc/H14-15-2006E.pdf. Accessed January 28, 2014.